$13M for synthetic biology research – Innovators Magazine
Innovators Magazine |
$13M for synthetic biology research
Innovators Magazine Researchers in Australia are making advances in synthetic biology (SynBio) thanks to the support of a multi-million dollar fund. The CSIRO Synthetic Biology Future Science Platform (SynBio FSP) is a $13 million shot in the arm for the country’s … |
|
Spark’s Gene Therapy SPK-8011 to Treat Hemophilia A and B Advance in Clinical Trials
Hemophilia News Today Three patients who received SPK-8011 — a gene therapy developed by Spark Therapeutics — for hemophilia A show increased production of clotting factor VIII without any safety issues reported, says the company. The patients are the first to receive the … |
BusinessCloud |
Stem cell disrupter WideCells raises £750k
BusinessCloud A company which aims to facilitate the use of stem cells in treating disease has raised £750,000 in a private placing and been named among the world’s most disruptive companies. WideCells Group PLC is based at the University of Manchester Innovation … |
|
Monsanto, ToolGen reach agreement on CRISPR technology
Wallace’s Farmer The license provides Monsanto with access to ToolGen’s comprehensive suite of CRISPR intellectual property for use in plants. This agreement further expands Monsanto’s portfolio of gene-editing tools that can be used to develop improved and sustainable … |
KSTP.com |
Inside Your Health: The DNA Editor ‘Crispr‘
KSTP.com There have been major advancements within the past couple weeks to a technology that edits DNA. The technique is referred to as “crispr” — and it has gripped scientists across the world over the past few years. Advertisement. KSTP medical expert … |
KSTP.com |
Inside Your Health: The DNA Editor ‘Crispr‘
KSTP.com There have been major advancements within the past couple weeks to a technology that edits DNA. The technique is referred to as “crispr” — and it has gripped scientists across the world over the past few years. Advertisement. KSTP medical expert … |